We are live on ! Find out more
IAM

Innovis Asset Management Portfolio holdings

AUM $260M
1-Year Est. Return 28.13%
This Fund
S&P 500
This Quarter Est. Return
+10.77%
1 Year Est. Return
+28.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$271M
AUM Growth
+$24.2M
Cap. Flow
+$3.94M
Cap. Flow %
1.45%
Top 10 Hldgs %
35%
Holding
186
New
25
Increased
37
Reduced
82
Closed
24

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$4.52M
2
ROK icon
Rockwell Automation
ROK
+$4.16M
3
NEM icon
Newmont
NEM
+$3.45M
4
EMR icon
Emerson Electric
EMR
+$3.41M
5
MSFT icon
Microsoft
MSFT
+$2.94M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.32M
2
FCX icon
Freeport-McMoran
FCX
+$3.32M
3
CTVA icon
Corteva
CTVA
+$3.26M
4
DVN icon
Devon Energy
DVN
+$3.24M
5
UNH icon
UnitedHealth
UNH
+$2.68M

Sector Composition

Rank Sector Weight
1 Technology 31.6%
2 Healthcare 22.77%
3 Financials 8.72%
4 Energy 6.58%
5 Consumer Staples 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNB
126
DELISTED
Dun & Bradstreet
DNB
$276K 0.1%
+23,896
New +$260K
COGT icon
127
Cogent Biosciences
COGT
$7.24B
$271K 0.1%
22,854
+133
+0.6% +$1.53K
VZ icon
128
Verizon
VZ
$196B
$270K 0.1%
+7,254
New +$268K
RVNC
129
DELISTED
Revance Therapeutics, Inc.
RVNC
$266K 0.1%
+10,517
New +$328K
SDGR icon
130
Schrodinger
SDGR
$1.36B
$265K 0.1%
5,316
-4,712
-47% -$159K
TD icon
131
Toronto Dominion Bank
TD
$200B
$261K 0.1%
4,216
-62
-1% -$3.73K
BMO icon
132
Bank of Montreal
BMO
$127B
$256K 0.09%
2,840
-39
-1% -$3.45K
GTLS
133
DELISTED
Chart Industries
GTLS
$255K 0.09%
+1,595
New +$204K
ERAS icon
134
Erasca
ERAS
$6.39B
$253K 0.09%
91,800
+48,363
+111% +$138K
WMT icon
135
Walmart Inc
WMT
$890B
$251K 0.09%
4,800
– –
SRE icon
136
Sempra
SRE
$54.8B
$250K 0.09%
3,436
-40
-1% -$3K
PLRX icon
137
Pliant Therapeutics
PLRX
$65M
$249K 0.09%
+13,762
New +$326K
CDW icon
138
CDW
CDW
$17B
$248K 0.09%
+1,350
New +$236K
GS icon
139
Goldman Sachs
GS
$303B
$244K 0.09%
757
-4
-0.5% -$1.31K
TARS icon
140
Tarsus Pharmaceuticals
TARS
$2.84B
$237K 0.09%
13,141
+82
+0.6% +$1.3K
DUK icon
141
Duke Energy
DUK
$97.3B
$237K 0.09%
2,642
-37
-1% -$3.49K
DOMO icon
142
Domo
DOMO
$184M
$233K 0.09%
+15,893
New +$235K
IJH icon
143
iShares Core S&P Mid-Cap ETF
IJH
$127B
$230K 0.09%
4,400
– –
XAIR icon
144
Beyond Air
XAIR
$3.86M
$229K 0.08%
134
+65
+94% +$149K
SWTX
145
DELISTED
SpringWorks Therapeutics
SWTX
$226K 0.08%
+8,613
New +$226K
AMX icon
146
America Movil
AMX
$71.2B
$220K 0.08%
10,172
-100
-1% -$2.17K
PTLO icon
147
Portillo's
PTLO
$321M
$215K 0.08%
+9,522
New +$198K
NDLS icon
148
Noodles & Co
NDLS
$107M
$207K 0.08%
7,671
+53
+0.7% +$1.73K
MGTX icon
149
MeiraGTx Holdings
MGTX
$1.21B
$205K 0.08%
+30,496
New +$196K
DVAX
150
DELISTED
Dynavax Technologies
DVAX
$198K 0.07%
+15,328
New +$175K
4 5
6
7 8

Similar funds

RCGI
Ribbit Capital GP II Palo Alto, California $260M AUM 2.87% 1-Year Est. Return
RBGI
Ribbit Bullfrog GP II Palo Alto, California $258M AUM 33.43% 1-Year Est. Return
AEPLI
AH Equity Partners LSV III Menlo Park, California $262M AUM 59.24% 1-Year Est. Return
PWM
PRW Wealth Management Quincy, Massachusetts $262M AUM 22.64% 1-Year Est. Return
T
TRUADVICE Sarasota, Florida $255M AUM 14.45% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
W
WealthOne Albany, New York $248M AUM 17.79% 1-Year Est. Return

Innovis Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Innovis Asset Management held 186 positions worth $271M, up 9.8% from $247M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Innovis Asset Management's Q2 2023 filing shows 25 new, 37 increased, 82 reduced and 24 closed positions. Its largest new stake was DexCom: 37,345 shares worth $4.8M. The largest sale was Pfizer, an estimated $5.32M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Innovis Asset Management's largest Q2 2023 buy was DexCom: 37,345 shares worth $4.8M.
  • Innovis Asset Management added most to Newmont in Q2 2023, an estimated $3.45M increase.
  • Innovis Asset Management's biggest Q2 2023 reduction was Pfizer, cutting an estimated $5.32M.
  • Innovis Asset Management fully exited Freeport-McMoran in Q2 2023, selling an estimated $3.32M.
  • Innovis Asset Management's ten largest holdings make up 35% of its $271M portfolio in Q2 2023.
  • Innovis Asset Management opened 25 new positions and closed 24 in Q2 2023.
  • Innovis Asset Management's portfolio value rose 9.8% quarter-over-quarter to $271M.

Based on Innovis Asset Management's 13F filing for Q2 2023, filed 3 Aug 2023.